Crowdonomics
All companies
Mylo Medical logo

Mylo Medical

Operating

Mylo Medical Supplies LLC

Healthcare · Willoughby, OH

Mylo Medical Supplies develops the MyloPan, an inflatable, sealed bedpan with a disposable waste-collection liner, meant to be more comfortable and leak-resistant than rigid bedpans. It targets hospitals, long-term care, rehab, hospice and home care, selling units plus recurring liners.

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$119,958
Crowd $30K · Private $90K · 2 rounds since 2025
Latest share price
$1.00
Reg CF · Common Stock · Feb 2026 offering price

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$0
2023
$0
−$27K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$27,200
Taxes paid
$0
$0
Balance sheet
Cash
$0
$24,511
Accounts receivable
$0
$0
Total assets
$0
$24,511
Short-term debt
$0
$0
Long-term debt
$0
$30,000
Total liabilities
$0
$30,000
Other
Headcount
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Raised $30K / $750K

Team

2 people
Nadia Tedeschi
Principal Executive Officer
Thomas Ross
Board Member

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-USep 8, 20260001669191-26-000271
    EDGAR
  • Form C/AJul 24, 20260001669191-26-000234
    EDGAR
  • Form C/AMay 21, 20260001669191-26-000181
    EDGAR
  • Form CFeb 25, 20260001669191-26-000045
    EDGAR
Source: SEC EDGARCIK 0002112197OHShare price $1.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.